Sinsin Pharmaceutical Co., Ltd (KOSDAQ:002800)
 5,360.00
 -40.00 (-0.74%)
  At close: Oct 28, 2025
Sinsin Pharmaceutical Revenue
Sinsin Pharmaceutical had revenue of 29.60B KRW in the quarter ending June 30, 2025, with 0.47% growth. This brings the company's revenue in the last twelve months to 107.13B, up 1.79% year-over-year. In the year 2024, Sinsin Pharmaceutical had annual revenue of 106.39B with 3.71% growth.
Revenue (ttm) 
 107.13B
Revenue Growth 
 +1.79%
P/S Ratio 
 0.73
Revenue / Employee 
 300.92M
Employees 
 356
Market Cap 
78.73B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 106.39B | 3.80B | 3.71% | 
| Dec 31, 2023 | 102.59B | 10.66B | 11.60% | 
| Dec 31, 2022 | 91.93B | 17.92B | 24.21% | 
| Dec 31, 2021 | 74.01B | 6.88B | 10.25% | 
| Dec 31, 2020 | 67.13B | -725.72M | -1.07% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| Samsung Electronics | 315.59T | 
| Hyundai Motor Company | 182.25T | 
| Kia Corporation | 111.04T | 
| SK hynix | 84.09T | 
| LG Energy Solution | 25.16T | 
| Hanwha Aerospace | 19.25T | 
| Doosan Enerbility | 16.30T | 
| HD Hyundai Heavy Industries | 15.58T |